It would only cost them $A6.2mil - they're going to be making more than that on a free cash flow basis each quarter from now. I think they'd be rats not to pay it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025